Companies: 10,795·Total market cap: $144.5T
Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

APLTNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$14862969
P/E Ratio
52W High$1.5
52W Low$0.09
Overview

Applied Therapeutics, Inc.(APLT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · APLT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.46M$9.99M$0.00M$0.00M$0.00M
Cost of Revenue$48.74M$53.91M$0.44M$0.00M$0.00M
Gross Profit($48.29M)($43.91M)($0.44M)$0.00M$0.00M
Gross Margin %(computed)-439.43%
Operating Expenses
R&D Expenses$48.74M$53.91M$55.63M$62.57M$61.79M
G&A Expenses$56.01M$20.62M$27.32M$43.05M$32.68M
Total Operating Expenses$56.01M$20.62M$82.51M$105.62M$94.47M
Operating Income($104.30M)($64.53M)($82.95M)($105.62M)($94.47M)
Operating Margin %(computed)-645.80%
Interest Income$3.53M$1.37M$0.69M$0.56M$0.56M
Interest Expense$0.00M$0.00M$0.00M$0.56M$0.56M
Income Before Tax($105.62M)($119.76M)($82.51M)($105.58M)($93.96M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($105.62M)($119.76M)($82.51M)($105.58M)($93.96M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.76$-1.42$-2.18$-4.12$-4.28
Wtd Avg Shares139.53M84.24M37.83M25.60M21.97M
EBITDA($104.30M)($64.53M)($82.07M)($105.62M)($94.47M)
EBITDA Margin %(computed)-645.79%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Applied Therapeutics, Inc.

关于Applied Therapeutics, Inc.(APLT)损益表

Applied Therapeutics, Inc.(APLT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,APLT实现营收$0.00B,毛利润($0.05B)(毛利率-10612.97%),净利润($0.11B)(净利率-23214.07%)。

常见问题

APLT · 4 问

Applied Therapeutics, Inc.(APLT)2024财年营收为$0.00B,同比down95.4%。

APLT revenueAPLT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08